A double blind evaluation of cognitive decline in a Norwegian cohort of asymptomatic carriers of Huntington's disease

Journal of Clinical and Experimental Neuropsychology

Volumn 32, Issue 6, 2010, Pages 590-598

  Van Walsem, Marleen R ^a   Sundet, Kjetil ^b   Retterstøl, Lars ^c   Sundseth, Øyvind ^c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Asymptomatic; Cognition; Cytosine adenine guanine; Huntington's disease; Proximity to disease onset

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; COGNITION DISORDERS; COHORT ANALYSIS; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPIDEMIOLOGY; FEMALE; GENETICS; HUMAN; HUNTINGTON CHOREA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NORWAY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TRINUCLEOTIDE REPEAT;

ADULT; ANALYSIS OF VARIANCE; COGNITION DISORDERS; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NORWAY; RETROSPECTIVE STUDIES; TRINUCLEOTIDE REPEATS;

EID: 77954406794     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803390903337878     Document Type: Article

References (55)

1. Andrews, T. C., Weeks, R. A., Turjanski, N., Gunn, R. N., Watkins, L. H., Sahakian, B., et al. (1999). Huntington's disease progression: PET and clinical observations. Brain, 122, 2353-2363.
2. Antonini, A., Leenders, K. L., Spiegel, R., Meier, D., Vontobel, P., Weigell-Weber, M., et al. (1996). Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. Brain, 119, 2085-2095.
3. Aylward, E. H., Codori, A. M., Rosenblatt, A. A., Sherr, M., Brandt, J., Stine, O. C., et al. (2000). Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Movement Disorders, 15, 552-560.
4. Aylward, E. H., Sparks, B. F., Field, K. M., Yallapragada, V., Shpritz, B. D., Rosenblatt, A., et al. (2004). Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology, 63, 66-72.
5. Blackmore, L., Simpson, S. A., & Crawford, J. R. (1995). Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington's disease. Journal of Medical Genetics, 32, 358-362.
6. Bosnes, O. (2007). California Verbal Learning Test-II (CVLTII) utprøvd i et klinisk utvalg i Norge: Psykometriske egenskaper og krysskulturell valididet [The Norwegian Version of the California Verbal Learning Test-II (CVLT-II): Psychometric characteristics and cross cultural validity]. Tidsskrift for Nosk Psykologforening, 44, 887-892.
7. Brandt, J., Shpritz. B., Codori, A. M., Margolis, R., & Rosenblatt, A. (2002). Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals. Journal of the International Neuropsychological Society, 8, 918-924.
8. Campodonico, J. R., Aylward, E., Codori, A. M., Young, C., Krafft, L., & Magdalinski, M. (1998). When does Huntington's disease begin? Journal of the International Neuropsychological Society, 4, 476-483.
9. Campodonico, J. R., Codori, A. M., & Brandt, J. (1996). Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation. Journal of Neurology, Neurosurgery, and Psychiatry, 61, 621-624.
10. Ciarmiello, A., Canella, M., Lastoria, S., Simonelli, D. P. M., Frati, L., Rubinsztein, M. B., et al. (2006). Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. Journal of Nuclear Medicine, 47, 215-222.
11. De Boo, G. M., Tibben, A., Hermans, J., Jennekens-Schinkel, A., Maat-Kiviet, A., & Roos, R. A. C. (1999). Memory and learning are not impaired in presymptomatic gene carriers of Huntington's disease. Journal of Clinical and Experimental Neuropsychology, 21, 831-836.
12. De Boo, G. M., Tibben, A., Lanser, J. B. K., Jennekens-Schinkel, A., Hermans, J., Maat-Kiviet, A., et al. (1997). Early cognitive and motor symptoms in identified carriers of the gene for Huntington's disease. Archives of Neurology, 54, 1353-1357.
13. Delis, D. C., Kramer, J., Kaplan, E., & Ober, B. A. (1987). The California Verbal Learning Test (CVLT): Manual. New York: The Psychological Corporation.
14. Delis, D. C., Kramer, J., Kaplan, E., & Ober, B. A. (2000). The California Verbal Learning Test-Second Edition (CVLT-II) manual. San Antonio, TX: Psychological Corporation.
15. Delis, D. C., Kramer, J. H., Kaplan, E., & Ober, B. A. (2004). California Verbal Learning Test, Second Edition (CVLT-II). Norwegian manual supplement. Stockholm, Sweden: Pearson Assessment.
16. Farrow, M., Churchyard, A., Chua, P., Bradshaw, J. L., Chiu, E., & Georgiou-Karistianis, N. (2007). Attention, inhibition, and proximity to clinical onset in preclinical mutation carriers for Huntington's disease. Journal of Clinical and Neuropsychological Neuropsychology, 29, 235-246.
17. Foroud, T., Siemers, E., Kleindorfer, D., Bill, D. J., Hodes, M. E., Norton, J. A., et al. (1995). Cognitive scores in carriers of the Huntington's disease gene compares to non-carriers. Annals of Neurology, 37, 657-664.
18. Georgiou-Karistianis, N., Smith, E., Bradshaw, J. L., Chua, P., Lloyd, J., Churchyard, A., et al. (2003). Future directions in research with presymptomatic individuals carrying the gene for Huntington's disease. Brain Research Bulletin, 59, 331-338.
19. Gómez-Ansón, B., Alegret, M., Muñoz, E., Sainz, A., Monte, G. C., & Tolosa, E. (2007). Decreased frontal choline and neuropsychological performance in preclinical Huntington disease. Neurology, 68, 906-910.
20. Gusella, J. F., Wexler, N. S., & Conneally, P. M. (1983). A polymorphic DNA marker linked to Huntington's disease. Nature, 306, 234-238.
21. Hahn-Barma, V., Deweer, B., Dürr, A., Dode, C., Feingold, J., Pillon, B., et al. (1998). Are cognitive changes the first signs of Huntington's disease? A study of gene carriers. Journal of Neurology, Neurosurgery, and Psychiatry, 64, 172-177.
22. Heaton, R. K., Chelune, G. J., Talley, J. L., Kay, G. G., & Curtiss, G. (1993). Wisconsin Card Sorting Test manual revised and expanded. Odessa, FL: Psychological Assessment Resources.
23. Huntington's Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
24. International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea (1994). Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology, 44, 1533-1536.
25. Johnson, S. A., Stout, J. C., Solomon, A. C., Langbehn, D. R., Aylward, E. H., Cruce, C. B., et al. (2007). Beyond disgust: Impaired recognition of negative emotions prior to diagnosis in Huntington's disease. Brain, 130, 1732-1744.
26. Kipps, C. M., Duggins, A. J., Mahant, N., Gomes, L., Ashburner, J., & McCusker, E. A. (2005). Progression of structural neuropathology in preclinical Huntington's disease: A tensor based morphometry study. Journal of Neurology, Neurosurgery and Psychiatry, 76, 650-655.
27. Kirkwood, S. C., Siemers, E., Hodes, M. E., Conneally, P. M., Christian, J. C., & Foroud, T. (2000). Subtle changes among pre-symptomatic carriers of the Huntington's disease gene. Journal of Neurology, Neurosurgery, and Psychiatry, 69, 773-779.
28. Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., & Hayden, M. R. (2004). A new model for prediction of the age at onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics, 62, 267-277.
29. Larrabee, G. J., Trahan, D. E., & Curtiss, G. (1992). Construct validity of the Continuous Visual Memory Test. Archives of Clinical Neuropsychology, 7, 395-405.
30. Larsson, M., Lundin, A., & Robins-Wahlin, T.-B. (2006). Olfactory functions in asymptomatic carriers of the Huntington disease mutation. Journal of Clinical and Experimental Neuropsychology, 28, 1373-1380.
31. Lawrence, A. D., Hodges, J. R., Rosser, A. E., Kershaw, A., ffrensh-Constant, C., Rubinsztein, D. C., et al. (1998). Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain, 12, 1329-1341.
32. Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G., & Dom, R. (2002). Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of Huntington's disease mutation after 1 year. Acta Neurologica Scandinavica, 106, 131-141.
33. Levin, B. C., Richie, K. L., & Jakupciak, J. P. (2006). Advances in Huntington's disease diagnostics: Development of a standard reference material. Expert Review of Molecular Diagnostics, 6, 587-596.
34. Lund-Johansen, M., Hughdal, K., & Wester, K. (1996). Cognitive function in patients with Parkinson's disease undergoing stereotactic thalamotomy. Journal of Neurology, Neurosurgery, and Psychiatry, 60, 564-571.
35. Matthews, C. G., & Kløve, H. (1964). Instruction manual for the Adult Neuropsychology Test Battery. Madison, WI: University of Wisconsin Medical School.
36. Meyers, J. E., & Meyers, K. R. (1995). Rey Complex Figure Test and Recognition Trial. Odessa, FL: Psychological Assessment Resources.
37. Milders, M., Crawford, J. R., Lamb, A., & Simpson, S. A. (2003). Differential deficits in expression recognition in gene-carriers and patients with Huntington's disease. Neuropsychologia, 41, 1484-1492.
38. Mitrushina, M. N., Boone, K. B., Razani, J., & D'Elia, L. F. (2005). Handbook of normative data for neuropsychological assessment (2nd ed.). New York: Oxford University Press.
39. Paulsen, J. S., Hayden, M., Stout, J. C., Langbehn, D. R., Aylward, E., Ross, C. A., et al. (2006). Preparing for preventive clinical trials. Archives of Neurology, 63, 883-890.
40. Paulsen, J. S., Langbehn, D. R., Stout, J. C., Ross, C. A., Nance, M., Guttman, M., et al. (2008). Detection of Huntington's disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery, and Psychiatry, 79, 874-880.
41. Paulsen, J. S., Zhao, H., Stout, J. C., Brinkman, R. R., Guttman, M., Ross, C. A., et al. (2001). Clinical markers of early disease in persons with near onset of Huntington's disease. Neurology, 57, 658-662.
42. Reitan, R. M. (1958). Validity of the Trail Making test as an indicator of organic brain damage. Perceptual Motor Skills, 8, 271-276.
43. Robins-Wahlin, T. B., Lundin, A., & Dear, K. A. (2007). Early cognitive deficits in Swedish gene carriers of Huntington's disease. Neuropsychology, 21, 31-44.
44. Rothlid, J. C., Brandt, J., Zee, D., Codori, A. M., & Folstein, S. (1993). Unimpaired verbal memory and ocular control in asymptomatic adults with the genetic marker for Huntington's disease. Archives for Neurology, 50, 799-802.
45. Rubinsztein, D. C., Leggo, J., Chiano, M., Dodge, A., Norbury, G., Rosser, E., & Craufurd, D. (1997). Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proceedings of the National Academy of Sciences, 94, 3872-3876.
46. Snowden, J. S., Craufurd, D., Thompson, J., & Neary, D. (2002). Psychomotor, executive and memory function in preclinical Huntington's disease. Journal of Clinical and Experimental Neuropsychology, 24, 133-145.
47. Solomon, A. J., Stout, J. C., Shannon, A. C., Langbehn, D. R., Aylward, E. H., Brandt, J., et al. (2007). Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia, 45, 1767-1776.
48. Spreen, O., & Strauss, E. (1991). A compendium of neuropsychological tests. New York: Oxford University Press.
49. Stout, J. C., Weaver, M., Solomon, A. C., Queller, S., Hui, S., Shannon, A., et al. (2007). Are cognitive changes progressive in prediagnostic HD? Cognitive and Behavioural Neurology, 20, 212-218.
50. Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., et al. (2007). Microglial activation in presymptomatic Huntington's disease gene carriers. Brain, 130, 1759-1766.
51. Verny, C., Allain, P., Prudean, A., Malinge, M.-C., Gohier, B., Scherer, C., et al. (2007). Cognitive changes in asymptomatic carriers of the Huntington's disease mutation gene. European Journal of Neurology, 14, 1344-1350.
52. Weschler, D. (1978). Wechsler Adult Intelligence Scale (WAIS). Norwegian manual. Oslo, Norway: Harald Engvik, Olav Hjerkinn og Sol Seim.
53. Wechsler, D. (2003). Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). Norwegian manual supplement. Stockholm, Sweden: Pearson Assessment.
54. Witjes-Ané, M. N., Mertens, B., van Vugt, J. P. P., Bachoud Lévi, A. C., van Ommen, G.-J. B., & Roos, R. A. C. (2007). Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease. Journal of Neuropsychiatry and Clinical Neuroscience, 19, 310-317.
55. Witjes-Ané, M. N., Vegter-Van der Vlis, M., Van Vugt, J. P. P., Lanser, J. B., Hermans, J., Zwinderman, A. H., et al. (2003). Cognitive and motor functioning in gene carriers for Huntington's disease: A baseline study. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 7-16.